Company: Tesaro: a GSK Company
Job title: Scientific Team Leader, Synthetic Lethality
Cancer Biologist with expertise in drug discovery and DNA damage response biology. Currently leading discovery biology and MOA studies focusing on identifying new synthetic lethal drug targets and drug combinations as part of the newly established Synthetic Lethality research unit of Tesaro/GSK in Waltham.
PARPi’s in NSCLC: A Comparative Analysis of Homologous Recombination Deficiency & PARPi Synthetic Lethality in Lung Cancer 11:30 am
day: Day Two